Abstract
Tissue polypeptide antigen (TPA) was originally described by Björklund and Björklund (1957). It was isolated from the insoluble residues of pooled tumors. Horse antiserum against the protein recognized both soluble form of TPA in human sera and body fluids, and an insoluble form in human tissues. Originally TPA was thought to be a tumor marker and, more recently, a proliferation marker (Björklund, 1980). TPA levels are elevated in the sera of patients with carcinomas, including breast cancer and tumor of the gastrointestinal, urogenital, and respiratory tract (Menendez-Botet et al., 1978; Björklund, 1980; Lüthgens and Schlegel, 1980, 1983, 1985; Schlegel et al., 1981; Skryten et al., 1981; Oehr et al., 1981, 1982b, 1984a; Inoue et al., 1985; Panucci et al., 1985, 1986; Salvati et al., 1985; Mross et al., 1985; Liu et al., 1989). The correlation between serological TPA levels and tumor progression has been studied for several years (Björklund, 1980; Lüthgens and Schlegel, 1980, 1985; Skryten et al., 1981; Inoue et al., 1985; Salvati et al., 1985). Generally there is an inverse relationship between TPA level and a favorable prognosis (Björklund, 1980; Lüthgens and Schlegel, 1980, 1985; Schlegel et al., 1981; Oehr et al., 1984a; Salvati et al., 1985; Bönnen et al., 1989). Serum and urinary TPA determinations show the highest sensitivity for early tumor detection in urinary bladder cancer. This is the case for transitional bladder cancer (Adolphs and Oehr, 1984, Oehr et al., 1984a; Costello et al., 1985; Carbin et al., 1989) as well as squamous cell cancer (El-Ahmady et al., 1989). There are isolated reports of elevated TPA levels in serum of patients with tumors other than carcinomas, e.g., in lymphoma (Inoue et al., 1985).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adolphs, H. D. and P. Oehr (1984), Urol Res. 12125.
Björklund, B. and V. Björklund (1957), Int. Arch. Allergy 10153–184.
Björklund, B., B. Wiklund, B. Lüning, K. Andersson, E. Kallin, and V. Björklund (1980) Tumor Diagnostik 2 78–84.
Bönnen, U., P. Oehr, U. Bönnen, Q. Liu, and H. J. Biersack (1989), Med. Nucl. 1 355–365.
Carbin, B.-E., P. Ekman, P. Eneroth, and B. Nilson (1989), Urol Res. 17 269–272.
Costello, C. B. and S. Kumar (1985), J. Royal Soc. Med. 78 207–210.
Drahovsky, D., S. Kaul, and H. P. Zimmerman (1984), Protides of the Biological Fluids, vol. 32, Pergamon, Oxford, New York, pp. 719–722.
El-Ahmady, O., S. Hamza, M. Aboul-Ela, A. B. Halim, and P. Oehr (1989),Recent Results in Tumor Diagnosis and Therapy (R. Klapdor, ed.), W.Zuckschwerdt Verlag, München, San Francisco, pp. 55230–55236.
Hanukoglu, I. and E. Fuchs (1982), Cell 31 243–252.
Hanukoglu, I. and E. Fuchs (1983), Cell 33 915–924.
Inaba, N., I. Fukazawa, Y. Ota, A. Nito, M. Ijichi, T. Sato, and H Takamizawa (1985), Acta Obst. Gynaec. Jpn. 37 2139–2140.
Inoue, M., Y. Inoue, D. Hirmatsu, and G. Ueda (1985), Cancer 55, 2618–2623.
Kirsch, J., P. Oehr, and C. Winkler (1983) Tumordiagn. u. Ther. 4 222–224.
Leube, R. E., F. X. Bosch, V. Romano, R. Zimbelmann, H. Höfler, and W. W. Franke (1986), Differentiation 33 69–85.
Liu, W., P. Oehr, M. Meier, M. Altreuther, J. Pollok, B. Schultes, U. Kania, A. Müller, M. Frings, A. Hirner, and H. J. Biersack (1989b), Recent Results in Tumor Diagnosis and Therapy (R. Klapdor, ed.), W. Zuckschwerdt Verlag, München, San Francisco, pp. S5167–S5170.
Liu, W., P. Oehr, U. Loos, B. Schultes, M. Praum, and H. J. Biersack (1989a),Recent Results in Tumor Diagnosis and Therapy (R. Klapdor, ed.), W.Zuckschwerdt Verlag, München, San Fransisco, pp. 5267–5269.
Liu, Q., M. Nap, and P. Oehr (1991), Tumordiagn. u. Ther. submitted.
Lüning, B., B. Wiklund, P. Redelius, and B. Björklund (1980), Biochem.Biophys. Acta 634 90–101.
Lüning, B., U. Nilsson, Lüning, M., and G. Thuresson (1985) Protides of the Biological Fluids, vol. 32, (H. Peeters, ed.), Pergamon, Oxford, New York, pp. 717–718.
Lüthgens, M. and G. Schlegel (1980), Tumor Diagn. 2 63–77.
Lüthgens, M. and G. Schlegel (1983), Cancer Detect. Prevent. 6 51–59.
Lüthgens, M. and G. Schlegel (1985), Tumordiagn. u. Ther. 61–7.
Margin, T. M., J. L. Jorcano, and W. W. Franjkke (1986), Differentiation 30254–264.
Menendez-Botet, C. J., H. F. Oettgen, C. M. Pinsky, and M. K. Schwarz (1987), Clin. Chem. 24 868–872.
Mross, K. B., D. I. Wolfrum, and H. Rauchrecker (1985), Oncology 42, 288–295.
Nathrath, W. B. J., P. Heidenkummer, H. Arnholdt, R. Bassermann, U. Löhrs, W. Permanetter, K. Remberger, and B. Wiebecke (1984), Protides of the Biological Fluids,vol. 31 (H. Peeters, ed.), Pergamon, Oxford, pp. 437–440.
Nathrath, W. B. J., P. Heidenkummer, V. Björklund, and B. Björklund (1985), J. Histochem. Cytochem. 33, 99–109.
Ochi, Y., Y. Ura, M. Hamazu, M. Ishida, Y. Kajita, and Y. Nakajima (1985), Clinica Chimica Acta 15157–167.
Oehr, P., G. Derigs, and R. Altmann (1981), Tumor Diagn. 2,283–290.
Oehr, P., O. Bellmann, and D. Hamann (1982a), Clin. Biochem. 1513–16.
Oehr, P., L. Fischer, W. Kerjes, U. Kunath, H. J. Biersack, U. Sipeer, and C. Winkler (1982b), Tumordiagn. Ther. 3,195–198.
Oehr, P. and J. Vogel (1984), in Protides of the Biological Fluids, vol. 31 (H. Peeters, ed.), Pergamon, Oxford, pp. 727–730.
Oehr, P., L. Fischer, W. Kerjes, H. D. Adolphs, H. J. Biersack, and C. Winkler (1984a), Campact News in Nucl. Med. 15152–154.
Oehr, P., J. Vogel, A. Lichius, B. Selbach, H.-J. Biersack, C. Winkler, and P. Gedigk (1984b), Tumordiagn. Ther. 5,129–138.
Oehr, P., J. Vogel, and M. Kramer (1986), Arztl. Lab. 32,166–172.
Oehr, P., Q. Liu, M. Nap, B. Schultes, M. Lechmann, Y. Ota, and H. Y. Jin (1991), Tumordiagn. Ther. submitted.
Panucci, A., C. Fabris, C. Del Favero, D. Basso, L. Marichioro, A. Piccoli, A. Rurlina, and R. Naccarato (1985), Br. J. Cancer 52, 801–807.
Panucci, A., C. Fabris, G. Del Favero, D. Basso, F. Di Mario, L. Marchioro, A. Piccoli, M. Lise, A. Burlina, and R. Naccarato (1986), J. Clin. Pathol.39 75–77.
Rasmuson, T., G. R. Björk, L. Damber, S. E. Holm, L. Jacobsson, A. Jeppsson, B. Littbrand, T. Stigbrand, and G. Westman (1983), Recent Results Cancer Res. 84 331–343.
Redelius, P., B. Lüning, and B. Björklund (1980), Acta Chem. Scand. B 34 265–273.
Salvati, F., A. R. Cruciani, F. Flore, G. De Angelis, F. Pigorini, A. Antilli, F. Pau, R. Munno, and A. Cipri (1985),Cancer Detect. Prvent. 8,111–114.
Schlegel, G., M. Lüthgens, G. Eklund, and B. Björklund (1981), Tumordiagn.Ther. 2 6–11.
Skryten, A., B. Unsgaard, B. Björklund, and G. Eklund (1981), Tumordiagn. Ther. 3117–120.
Sundström, B., B. Johansson, S. O. Hietala, and T. Stigbrand (1990), Tumor Biol. 11158–166.
Vogel, J. and P. Oehr (1985), in Protides of the Biological Fluids, vol. 32 (H. Peeters, ed.), Pergamon, Oxford, pp. 743–746.
Weber, K. and G. Geisler (1984), Cancer Cells 1. the Transformed Phenotype.Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 153–159.
Weber, K., M. Osborn, R. Moll, B. Wiklund, and B. Lüning (1984), EMBO J.,3,2707–2714.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Oehr, P., Lüthgens, M.L., Liu, Q. (1992). Tissue Polypeptide Antigen and Specific TPA. In: Sell, S. (eds) Serological Cancer Markers. Contemporary Biomedicine, vol 11. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0401-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0401-5_9
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4612-6745-4
Online ISBN: 978-1-4612-0401-5
eBook Packages: Springer Book Archive